Exploración del mecanismo patogénico y principios terapéuticos de la enfermedad pulmonar obstructiva crónica basados en la correlación bazo-mitocondria

  • role: First author第一作者
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

  • Email:2072943354@qq.com
  • Introduction:王诗怡,在读硕士,从事中医药治疗肺系疾病的基础和临床研究,E-mail:2072943354@qq.com
WANG Shiyi1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

YU Miao1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

HE Xinyao1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

WANG Zi1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

LUAN Haijun1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

SUN Yibo1,  
  • Affiliation:

    Liaoning University of Traditional Chinese Medicine(TCM),Shenyang 110847,China

WANG Haotong1,  
  • Affiliation:

    Affiliated Hospital of Liaoning University of TCM,Shenyang 110000,China

WANG Linlin2,  
  • role: Corresponding author通信作者
  • Affiliation:

    Affiliated Hospital of Liaoning University of TCM,Shenyang 110000,China

  • Email:hahaya123@126.com
  • Introduction:庞立健,博士,主任中医师,博士生导师,从事中医药治疗肺系疾病的基础和临床研究,Tel:024-31961130,E-mail:hahaya123@126.com
PANG Lijian2*

resumen

Guiado por la "teoría del Qi, la sangre y el agua", centrado en la relación entre la función del bazo en la teoría藏象 de la medicina tradicional china y las mitocondrias en la biología celular moderna, se considera que la biosíntesis de Qi y sangre por el bazo es similar a la función productora de energía de las mitocondrias, ambos siendo fuentes de energía para la actividad vital del cuerpo; el bazo es clave en el metabolismo energético y la digestión y absorción de nutrientes; de igual manera, las mitocondrias son esenciales para el suministro de energía celular, la supervivencia celular y el mantenimiento de funciones fisiológicas metabólicas, y la insuficiencia esplénica está estrechamente relacionada con la disfunción mitocondrial. Por lo tanto, la conversión energética y el metabolismo material de las mitocondrias son la esencia microscópica de la función de transporte del bazo, y la insuficiencia esplénica y la disfunción mitocondrial son factores para la producción patológica de flema, estasis y estasis sanguínea, características que coinciden con la patogenia de la enfermedad pulmonar obstructiva crónica (EPOC) "deficiencia de Qi como base, flema y estasis sanguínea como signos". Por ello, en el tratamiento combinado de la EPOC con medicina tradicional china y occidental, se sigue el principio de fortalecer el bazo y tonificar el Qi, mientras se disuelve la flema y se elimina la estasis, atendiendo a causa y efecto. Esto puede mejorar la función mitocondrial, regular el metabolismo energético, reducir los niveles de estrés oxidativo, aliviar los síntomas de la EPOC, retardar la progresión de la enfermedad y mejorar el pronóstico. Esta teoría combina el concepto holístico de la medicina tradicional china con los mecanismos moleculares de la medicina moderna, explorando la patogenia y los principios terapéuticos de la EPOC desde la perspectiva "bazo-mitocondria", proporcionando una nueva dirección para la modernización de la medicina china y la integración de la medicina china y occidental, y ofreciendo una base teórica para el tratamiento integrado de enfermedades complejas crónicas asociadas al envejecimiento.

palabra clave

bazo;mitocondria;enfermedad pulmonar obstructiva crónica (EPOC);teoría del Qi, la sangre y el agua;estrés oxidativo

References

  1. 1.
    WANG C,XU J Y,YANG L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study):A national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.
  2. 2.
    YANG G H,WANG Y,ZENG Y X,et al.Rapid health transition in China,1990-2010:Findings from the Global Burden of Disease Study 2010[J].Lancet,2013,381(9882):1987-2015.
  3. 3.
    DECRAMER M,CELLI B,KESTEN S,et al.Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT):A prespecified subgroup analysis of a randomised controlled trial[J].Lancet,2009,374(9696):1171-1178.
  4. 4.
    PANG L J,ZANG N Z,LIU C,et al.Anti-inflammatory and immunomodulatory effects of Rehmannia glutinosa injection in the syndrome of phlegm-heat blocking lung in acute exacerbation of chronic obstructive pulmonary disease[J].World Sci Technol-Mod Tradit Chin Med,2015,17(6):1225-1229.
  5. 5.
    CHRISTENSON S A,SMITH B M,BAFADHEL M,et al.Chronic obstructive pulmonary disease[J].Lancet,2022,399(10342):2227-2242.
  6. 6.
    LIN Z W,XU Y F,GUAN L L,et al.Seven ferroptosis-specific expressed genes are considered as potential biomarkers for the diagnosis and treatment of cigarette smoke-induced chronic obstructive pulmonary disease[J].Ann Transl Med,2022,10(6):331.
  7. 7.
    LIU L,ZHANG Y S,WANG L,et al.Scutellarein alleviates chronic obstructive pulmonary disease through inhibition of ferroptosis by chelating iron and interacting with arachidonate 15-lipoxygenase[J].Phytother Res,2023,37(10):4587-4606.
  8. 8.
    HUANG J Y,WEI L,LIU F Y,et al.The role of mitochondrial autophagy in regulating cell senescence in COPD and the research progress of traditional Chinese medicine[J].J Shanghai Univ Tradit Chin Med,2024,38(5):94-100.
  9. 9.
    BARNES P J.COPD 2020:New directions needed[J].Am J Physiol Lung Cell Mol Physiol,2020,319(5):L884-L886.
  10. 10.
    HOUBEN-WILKE S,AUGUSTIN I M,VERCOULEN J H,et al.COPD stands for complex obstructive pulmonary disease[J].Eur Respir Rev,2018,27(148):180027.
  11. 11.
    LI C L,LIU S F.Cellular and molecular biology of mitochondria in chronic obstructive pulmonary disease[J].Int J Mol Sci,2024,25(14):7780.
  12. 12.
    BRAND M D,ORR A L,PEREVOSHCHIKOVA I V,et al.The role of mitochondrial function and cellular bioenergetics in ageing and disease[J].Br J Dermatol,2013,169(Suppl 2):1-8.
  13. 13.
    BOCK F J,TAIT S W G.Mitochondria as multifaceted regulators of cell death[J].Nat Rev Mol Cell Biol,2020,21(2):85-100.
  14. 14.
    GIBSON G E,XU H,CHEN H L,et al.α-ketoglutarate dehydrogenase complex-dependent succinylation of proteins in neurons and neuronal cell lines[J].J Neurochem,2015,134(1):86-96.
  15. 15.
    FANG Y,TANG S,LI X L.Sirtuins in metabolic and epigenetic regulation of stem cells[J].Trends Endocrinol Metab,2019,30(3):177-188.
  16. 16.
    WU C M,GUAN P.Research progress on the pathogenesis and drug targets of sarcopenia in chronic obstructive pulmonary disease[J].Hainan Med J,2024,35(22):3331-3334.
  17. 17.
    WIEGMAN C H,MICHAELOUDES C,HAJI G,et al.Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease[J].J Allergy Clin Immunol,2015,136(3):769-780.
  18. 18.
    LÓPEZ-OTÍN C,BLASCO M A,PARTRIDGE L,et al.Hallmarks of aging:An expanding universe[J].Cell,2023,186(2):243-278.
  19. 19.
    LIU L,SAKAKIBARA K,CHEN Q,et al.Receptor-mediated mitophagy in yeast and mammalian systems[J].Cell Res,2014,24(7):787-795.
  20. 20.
    YANG L P,YAN P P,HUANG R,et al.Research on the activities of mitochondrial respiratory chain complex I in the syndromes of deficiency cold and deficiency heat[J].Chin J Tradit Chin Med,2014,29(11):3440-3442.
  21. 21.
    ARUMUGAM P,SAMSON A,KI J,et al.Knockdown of clusterin alters mitochondrial dynamics,facilitates necrosis in camptothecin-induced cancer stem cells[J].Cell Biol Toxicol,2017,33(3):307-321.
  22. 22.
    MILLS E L,KELLY B,O'NEILL L A J.Mitochondria are the powerhouses of immunity[J].Nat Immunol,2017,18(5):488-498.
  23. 23.
    AHMAD T,SUNDAR I K,LERNER C A,et al.Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence:Implications for chronic obstructive pulmonary disease[J].FASEB J,2015,29(7):2912-2929.
  24. 24.
    MIZUMURA K,CLOONAN S M,NAKAHIRA K,et al.Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD[J].J Clin Invest,2014,124(9):3987-4003.
  25. 25.
    FERNANDEZ-VIZARRA E,ZEVIANI M.Mitochondrial disorders of the OXPHOS system[J].FEBS Lett,2021,595(8):1062-1106.
  26. 26.
    AGHAPOUR M,REMELS A H V,POUWELS S D,et al.Mitochondria:At the crossroads of regulating lung epithelial cell function in chronic obstructive pulmonary disease[J].Am J Physiol Lung Cell Mol Physiol,2020,318(1):L149-L164.
  27. 27.
    LEERMAKERS P A,SCHOLS A M W J,KNEPPERS A E M,et al.Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD)[J].Sci Rep,2018,8(1):15007.
  28. 28.
    DECRAMER M,JANSSENS W,MIRAVITLLES M.Chronic obstructive pulmonary disease[J].Lancet,2012,379(9823):1341-1351.
  29. 29.
    ALFAHAD A J,ALZAYDI M M,ALDOSSARY A M,et al.Current views in chronic obstructive pulmonary disease pathogenesis and management[J].Saudi Pharm J,2021,29(12):1361-1373.
  30. 30.
    WANG X L,FENG S T,WANG Z Z,et al.Parkin,an E3 ubiquitin ligase,plays an essential role in mitochondrial quality control in Parkinson's disease[J].Cell Mol Neurobiol,2021,41(7):1395-1411.
  31. 31.
    GIORDANO L,GREGORY A D,PÉREZ VERDAGUER M,et al.Extracellular release of mitochondrial DNA:Triggered by cigarette smoke and detected in COPD[J].Cells,2022,11(3):369.
  32. 32.
    SUN X,MEI X,XU J J,et al.Research progress on the treatment of common respiratory system diseases based on regulating mitochondrial autophagy by traditional Chinese medicine[J/OL].J Chin Pharmacol Clin Pract,2025,doi:.
  33. 33.
    KOSMIDER B,LIN C R,KARIM L,et al.Mitochondrial dysfunction in human primary alveolar type Ⅱ cells in emphysema[J].E Bio Med,2019,46:305-316.
  34. 34.
    GONZÁLEZ-SÁNCHEZ M,GARCÍA-MARTÍNEZ V,BRAVO S,et al.Mitochondrial DNA insertions into nuclear DNA affecting chromosome segregation:Insights for a novel mechanism of immunosenescence in mice[J].Mech Ageing Dev,2022,207:111722.
  35. 35.
    ZHENG M L.Hypothesis of the cellular biology of Zangxiang in traditional Chinese medicine (Part Ⅱ)[J].J Tradit Chin Med,2004,22(7):1235-1236,1291.
  36. 36.
    ZHANG T,CHEN N,JIA Q H,et al.Effects and mechanism of Liujunzi pill on intestinal flora in rats with spleen Qi deficiency syndrome[J].Chin J Tradit Chin Med,2025,50(15):4333-4341.
  37. 37.
    XIE K,LI C,WANG Y,et al.Exploring the theoretical connotation of "heart receiving Qi from spleen" based on the "spleen-mitochondria-heart" axis in heart failure[J].J Tradit Chin Med,2024,42(10):118-122.
  38. 38.
    NI F,YU R,CUI J P,et al.Effects of Xiangsha Liujunzi decoction on mitochondrial energy metabolism in rats with spleen Qi deficiency syndrome and superficial gastritis[J].Shaanxi J Tradit Chin Med,2020,41(2):152-155.
  39. 39.
    CAO H M,SONG N,JIA L Q,et al.iTRAQ-based analysis of changes in mitochondrial proteome in the heart of Ba Ma miniature pigs with spleen deficiency,hyperlipidemia and phlegm turbid syndrome[J].Lishizhen Med Mater Med Res,2016,27(7):1772-1774.
  40. 40.
    WANG J,WAN L S,NI X Q,et al.Effects of Yunpi Zhixie formula on short-chain fatty acids and energy metabolism in diarrheal rats based on "spleen-mitochondria related" research[J].Chin Herb Med,2024,47(3):697-704.
  41. 41.
    LIU Y Z,SONG Y F,LAO S X,et al.Ultrastructural study of gastric mucosa in patients with epigastric pain and discussion on the theory of "spleen-mitochondria related" in traditional Chinese medicine[J].J Tradit Chin Med,2007(12):2439-2442.
  42. 42.
    GÓMEZ J,MOTA-MARTORELL N,JOVÉ M,et al.Mitochondrial ROS production,oxidative stress and aging within and between species:Evidences and recent advances on this aging effector[J].Exp Gerontol,2023,174:112134.
  43. 43.
    ZHANG S H,XU D,YAN X J,et al.Effects of different organ deficiencies on the condition and mitochondrial function of patients with chronic obstructive pulmonary disease[J].World Sci Technol-Mod Tradit Chin Med,2018,20(3):446-452.
  44. 44.
    PANG L J,LYU X D,LIU C,et al.Insights into professor MA Zhi's treatment of internal medicine disorders with the method of "resolving phlegm and blood stasis,regulating qi and blood"[J].J Tradit Chin Med,2020,38(3):33-35.
  45. 45.
    ZHAO G Y,MIAO Y F,HOU R S,et al.Mitochondrial damage and skeletal muscle dysfunction in chronic obstructive pulmonary disease and progress in traditional Chinese medicine treatment[J].Chin J Comp Med,2022,32(2):133-137,144.
  46. 46.
    ZHANG L,DING H Z,XU H R,et al.Shenqi Buzhong formula improves mitochondrial dysfunction in rats with copd and spleen Qi deficiency syndrome by activating AMPK/SIRT1/PGC-1α[J].J South Med Univ,2025,45(5):969-976.
  47. 47.
    GAO Z,JING J,XU D,et al.A randomized controlled study of the Yi Qi Gu Biao pill in the treatment of frequent exacerbator phenotype in chronic obstructive pulmonary disease (lung and spleen Qi deficiency syndrome)[J].Evid Based Complement Alternat Med,2017,2017:9130804.
  48. 48.
    MENG T,XU D,MI YESER M,et al.Effects of Yiqi Guben pill on the expression of SIRT5 in mitochondria of chronic obstructive pulmonary disease cell models[J].J Mod Integr Med,2024,33(6):738-743.
  49. 49.
    ZHOU X Y,SONG Y H,XUE D,et al.Protective mechanism of Shenling Baizhu powder on COPD skeletal muscle injury cells based on mitophagy[J].J Guangdong Pharm Univ,2020,36(3):369-374.
  50. 50.
    PANG L J,LV X D,ZHAO Z X,et al.Scientific research and development ideas for chronic complex diseases in traditional Chinese medicine[J].China J Tradit Chin Med Pharm,2016,31(8):2894-2899.

Leer el texto completo

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website